Puma Biotechnology

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$56,136
$47,083
$43,766
$72,178
Gross Profit
27,039
36,425
33,038
47,855
EBITDA
26,586
2,129
1,661
18,312
EBIT
23,708
-779
-1,236
15,423
Net Income
20,317
-4,529
-4,815
12,268
Net Change In Cash
56,136
47,083
43,766
72,178
Free Cash Flow
11,018
1,006
11,246
10,410
Cash
67,263
67,149
76,751
84,585
Basic Shares
49,173
48,292
48,189
48,040

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$235,637
$228,000
$253,200
$225,100
Gross Profit
172,955
172,900
189,500
185,700
EBITDA
44,784
20,969
-5,397
-38,542
EBIT
33,265
12,049
-15,995
-45,742
Net Income
21,591
912
-29,100
-60,000
Net Change In Cash
235,637
228,000
253,200
225,100
Cost of Revenue
3,500
-22,162
24,244
Free Cash Flow
14,369
-22,800
20,700
-19,246
Cash
84,585
76,200
63,100
85,300
Basic Shares
47,550
44,929
40,638
39,576

Earnings Calls

Quarter EPS
2024-09-30
$0.41
2024-06-30
-$0.09
2024-03-31
-$0.10
2023-12-31
$0.26